James Lapworth is Chief Business Officer of NanoSyrinx Ltd. As part of the Founding Team, James was instrumental in spinning out the company from Warwick Medical School (UK) and raising over $20M in venture capital financing to date. Prior to NanoSyrinx, James was responsible for building 5 other NewCos in the biotech and medical device sectors and negotiating partnership and licensing deals spanning a range of therapeutic areas.